A Clinical Trial to Compare the Efficacy and Safety of a Combination Therapy of Ezetimibe and Rosuvastatin Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients (I-ROSETTE Study)

NCT02749994 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

396

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: Rosuvastatin
DRUG: Ezetimibe

Sponsor

IlDong Pharmaceutical Co Ltd